[Changes in quality of life in patients with remitted multiple sclerosis during the specific treatment with disease-modifying drugs: a comparative study of populations of Moscow and Novosibirsk]

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Pt 1):67-70.
[Article in Russian]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Depression / diagnosis
  • Female
  • Glatiramer Acetate
  • Humans
  • Interferon beta-1a
  • Interferon-beta / therapeutic use*
  • Male
  • Middle Aged
  • Moscow
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / drug therapy*
  • Peptides / therapeutic use*
  • Quality of Life*
  • Remission Induction
  • Severity of Illness Index
  • Siberia
  • Young Adult

Substances

  • Peptides
  • Glatiramer Acetate
  • Interferon-beta
  • Interferon beta-1a